This study is testing a new device called "calla" that aims to replace the speculum during a routine Pap smear for cervical cancer screening. The study is looking for women aged 21-65 who are generally healthy and have had a pelvic exam. You would either use the "calla" device during your Pap smear, or, if you're a healthy volunteer, take the device home for a week to see if you can find your cervix without a doctor's help. The main goal is to see how well the "calla" introducer works. The study plans to enroll 305 participants, but its current recruitment status is unclear.

Study design

This is an interventional study with an unspecified phase, planning to enroll 305 participants. It has two arms: one for patients undergoing a Pap smear and another for healthy volunteers.

What's involved

If you are a patient, the "calla" device will be used during your Pap smear. If you are a healthy volunteer, you will take the device home for a week and complete surveys.

Compensation

Not stated in the trial record.

Follow-up

The assessment of the introducer will be measured up to one week after the Pap smear for patients, and up to one week for healthy volunteers.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.